Curacle Co., Ltd.

Eyedea Inc.

Hyo Jin Park

Young Guen Kwon

Jinbyuk Hwang

Jang Dong Im

Ju Hong Park

The present invention relates to an unmanned aerial vehicle having an automatic tracking function and a control method thereof, the unmanned aerial vehicle comprising: an image input unit for acquiring an image of a peripheral image of a subject to be photographed; an object recognition unit for extracting a region of interest using the image acquired through the image input unit, detecting a specific region located within the region of interest to measure coordinates, and recognizing the specific region as an object to be tracked; an object tracking unit for calculating and tracking a position of the object to be tracked recognized by the object recognition unit using a tracking learning detection (TLD) learning algorithm and generating a drive command for driving the unmanned aerial vehicle corresponding to the position; a motion recognition unit for recognizing a motion of the object to be tracked and generating a driving command corresponding to a photographing mode, a moving picture photographing mode, and a return mode; and a drive control unit for driving the unmanned aerial vehicle according to the drive command. Due to this feature, the present invention has an effect of enabling autonomous flight of an unmanned aerial vehicle by recognizing and automatically tracking an object to be tracked.

Unmanned aerial vehicle having automatic tracking function and method of controlling the same

The present invention provides a decoy peptide or polypeptide capable of inhibiting the binding of AMIGO2 and 3-phosphoinositide-dependent kinase 1 (PDK1), and a pharmaceutical composition, containing the decoy peptide or polypeptide as an active ingredient, for preventing or treating cancer or an angiogenic disease. Furthermore, the present invention provides a method for screening a material for preventing or treating cancer or an angiogenic disease. According to the present invention, it is worth noting that the decoy peptide or polypeptide of the present invention induces apoptosis through the inhibition of the binding of AMIGO2 and 3-phosphoinositide-dependent kinase 1 (PDK1); reduces migration and adhesion of endothelial cells; significantly reduces vascular induction, survival, and growth. The decoy peptide or polypeptide of the present invention can contribute to the prevention or treatment of cancer or an angiogenic disease through the inhibition of Akt signaling, resulting from the inhibition of a direct interaction of the cytosolic domain of AMIGO2 and the PH domain of PDK1.

Growing community of inventors

Seoul, South Korea

Hyo Jin Park